Carlyle to Acquire Baxter’s Kidney Care Segment for $3.8 Billion, Establishing Vantive
Key Highlights Baxter sells Kidney Care segment to Carlyle for $3.8 billion, forming Vantive. Transaction supports Baxter’s strategic realignment and debt reduction.…
